Newsroom
With COVID-19 vaccines coming, SiO2 injects $163M into vial production plant
As COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging to store those shots. One Alabama-based materials manufacturer
BARDA and DoD work with SiO2 Materials Science to increase domestic manufacturing of vials
Increasing the capacity to manufacture vials in the United States can reduce U.S. dependence on foreign supply chains
Auburn plant expansion to support COVID-19 vaccine effort
AUBURN, Ala. (WSFA) – SiO2 Materials Science is investing $163 million in an expansion at its Auburn facility after securing a major contract to supply the federal government with vials to support the COVID-19 vaccine effort.
Company creating vials for COVID-19 vaccine brings more jobs to Auburn area
As COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging to store those shots. One Alabama-based materials manufacturer
SiO2 Scales Manufacturing of Hybrid Vial Capacity for 400 Million Doses of COVID-19 Vaccine Achieved Ahead of Schedule
As COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging
The US Might Not Have Enough Glass Vials to Distribute the Coronavirus Vaccines
As COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging to store those shots. One Alabama-based materials manufacturer